Zeda Rosenberg

4.8k total citations
47 papers, 2.5k citations indexed

About

Zeda Rosenberg is a scholar working on Infectious Diseases, Microbiology and Virology. According to data from OpenAlex, Zeda Rosenberg has authored 47 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 20 papers in Microbiology and 17 papers in Virology. Recurrent topics in Zeda Rosenberg's work include HIV/AIDS Research and Interventions (25 papers), Reproductive tract infections research (20 papers) and HIV Research and Treatment (17 papers). Zeda Rosenberg is often cited by papers focused on HIV/AIDS Research and Interventions (25 papers), Reproductive tract infections research (20 papers) and HIV Research and Treatment (17 papers). Zeda Rosenberg collaborates with scholars based in United States, Belgium and Tanzania. Zeda Rosenberg's co-authors include Anthony S. Fauci, Robin J. Shattock, Joseph Romano, Annaléne Nel, Bríd Devlin, Jeremy Nuttall, Paul Coplan, Mark Mitchnick, Anthony S. Fauci and Lut Van Damme and has published in prestigious journals such as Science, Annals of Internal Medicine and Clinical Infectious Diseases.

In The Last Decade

Zeda Rosenberg

45 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zeda Rosenberg United States 24 1.2k 1.0k 825 737 558 47 2.5k
Sengeziwe Sibeko South Africa 13 1.8k 1.5× 1.3k 1.3× 924 1.1× 659 0.9× 738 1.3× 28 2.9k
J. Neil Simonsen Canada 24 1.2k 1.0× 705 0.7× 857 1.0× 963 1.3× 639 1.1× 37 3.2k
Patricia Reichelderfer United States 27 2.1k 1.7× 1.9k 1.9× 972 1.2× 511 0.7× 286 0.5× 56 3.4k
Léopold Zekeng Cameroon 35 2.4k 1.9× 1.9k 1.9× 1.2k 1.5× 577 0.8× 716 1.3× 101 3.8k
Ian McGowan United States 33 2.2k 1.8× 1.6k 1.6× 1.3k 1.6× 726 1.0× 560 1.0× 132 3.5k
Lut Van Damme United States 25 1.8k 1.4× 712 0.7× 1.2k 1.4× 1.2k 1.6× 897 1.6× 57 2.9k
Lyle R. McKinnon Canada 32 1.2k 1.0× 1.1k 1.0× 1.2k 1.4× 1.1k 1.5× 545 1.0× 115 3.4k
Ayesha B. M. Kharsany South Africa 21 2.2k 1.8× 856 0.8× 1.3k 1.5× 795 1.1× 1.2k 2.1× 61 3.2k
Clyde E. Hart United States 26 1.0k 0.8× 1.2k 1.2× 664 0.8× 358 0.5× 146 0.3× 47 2.2k
Katrien Fransen Belgium 32 2.4k 2.0× 2.3k 2.2× 1.0k 1.3× 312 0.4× 229 0.4× 118 3.3k

Countries citing papers authored by Zeda Rosenberg

Since Specialization
Citations

This map shows the geographic impact of Zeda Rosenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeda Rosenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeda Rosenberg more than expected).

Fields of papers citing papers by Zeda Rosenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeda Rosenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeda Rosenberg. The network helps show where Zeda Rosenberg may publish in the future.

Co-authorship network of co-authors of Zeda Rosenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Zeda Rosenberg. A scholar is included among the top collaborators of Zeda Rosenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeda Rosenberg. Zeda Rosenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nel, Annaléne, Neliëtte van Niekerk, Ben Van Baelen, et al.. (2021). Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study. The Lancet HIV. 8(2). e77–e86. 71 indexed citations
2.
Woodsong, Cynthia, et al.. (2015). Recent work on vaginal rings containing antiviral agents for HIV prevention. Current Opinion in HIV and AIDS. 10(4). 264–270. 9 indexed citations
3.
Nel, Annaléne, Wouter Haazen, Jeremy Nuttall, et al.. (2014). A safety and pharmacokinetic trial assessing delivery of dapivirine from a vaginal ring in healthy women. AIDS. 28(10). 1479–1487. 60 indexed citations
4.
Devlin, Bríd, et al.. (2013). Development of dapivirine vaginal ring for HIV prevention. Antiviral Research. 100. S3–S8. 65 indexed citations
5.
Rosenberg, Zeda & Bríd Devlin. (2012). Future strategies in microbicide development. Best Practice & Research Clinical Obstetrics & Gynaecology. 26(4). 503–513. 29 indexed citations
6.
Shattock, Robin J. & Zeda Rosenberg. (2011). Microbicides: Topical Prevention against HIV. Cold Spring Harbor Perspectives in Medicine. 2(2). a007385–a007385. 97 indexed citations
7.
Romano, Joseph, Bruce Variano, Paul Coplan, et al.. (2009). Safety and Availability of Dapivirine (TMC120) Delivered from an Intravaginal Ring. AIDS Research and Human Retroviruses. 25(5). 483–488. 117 indexed citations
8.
Tassiopoulos, Katherine, George R. Seage, Noel Sam, et al.. (2007). Predictors of Herpes Simplex Virus Type 2 Prevalence and Incidence among Bar and Hotel Workers in Moshi, Tanzania. The Journal of Infectious Diseases. 195(4). 493–501. 31 indexed citations
9.
Kapiga, Saidi, Noel E. Sam, Heejung Bang, et al.. (2007). The Role of Herpes Simplex Virus Type 2 and Other Genital Infections in the Acquisition of HIV‐1 among High‐Risk Women in Northern Tanzania. The Journal of Infectious Diseases. 195(9). 1260–1269. 58 indexed citations
10.
Nuttall, Jeremy, Joseph Romano, Karen Douville, et al.. (2007). The Future of HIV Prevention: Prospects for an Effective Anti-HIV Microbicide. Infectious Disease Clinics of North America. 21(1). 219–239. 38 indexed citations
11.
Rosenberg, Zeda, Annaléne Nel, William L. Heyward, & Mark Mitchnick. (2006). Microbicides for the prevention of HIV infection in women: an overview of recent trials. Current Opinion in HIV and AIDS. 1(6). 514–519. 3 indexed citations
12.
Mayer, Kenneth H., Salim S. Abdool Karim, Clifton W. Kelly, et al.. (2003). Safety and tolerability of vaginal PRO 2000 gel in sexually active HIV-uninfected and abstinent HIV-infected women. AIDS. 17(3). 321–329. 76 indexed citations
13.
Mauck, Christine K., Zeda Rosenberg, & Lut Van Damme. (2001). Recommendations for the clinical development of topical microbicides: an update. AIDS. 15(7). 857–868. 62 indexed citations
14.
Barker, Lewellys F., Harold W. Jaffe, & Zeda Rosenberg. (1995). Prevention Research and Vaccine Preparedness: Conference Summary. AIDS Research and Human Retroviruses. 11(10). 1297–1299. 2 indexed citations
15.
Rosenberg, Zeda & Anthony S. Fauci. (1991). Immunopathology and pathogenesis of human immunodeficiency virus infection. The Pediatric Infectious Disease Journal. 10(3). 230–238. 10 indexed citations
16.
Rosenberg, Zeda & Anthony S. Fauci. (1990). Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Immunology Today. 11(5). 176–180. 246 indexed citations
17.
Rosenberg, Zeda & Anthony S. Fauci. (1989). The Immunopathogenesis of HIV Infection. Advances in immunology. 47. 377–431. 199 indexed citations
18.
Rosenberg, Zeda & Anthony S. Fauci. (1989). Immunology of aids: Approaches to understanding the immunopathogenesis of HIV infection. La Ricerca in Clinica e in Laboratorio. 19(1). 189–209. 9 indexed citations
19.
Rosenberg, Zeda & Anthony S. Fauci. (1989). Immunopathogenic mechanisms of HIV infection. Clinical Immunology and Immunopathology. 50(1). S149–S156. 40 indexed citations
20.
Rosenberg, Zeda & Anthony S. Fauci. (1989). Minireview: Induction of Expression of HIV in Latently or Chronically Infected Cells. AIDS Research and Human Retroviruses. 5(1). 1–4. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sengeziwe Sibeko Breakdown of academic impact, for papers by J. Neil Simonsen Breakdown of academic impact, for papers by Patricia Reichelderfer Breakdown of academic impact, for papers by Léopold Zekeng Breakdown of academic impact, for papers by Ian McGowan Breakdown of academic impact, for papers by Lut Van Damme Breakdown of academic impact, for papers by Lyle R. McKinnon Breakdown of academic impact, for papers by Ayesha B. M. Kharsany Breakdown of academic impact, for papers by Clyde E. Hart Breakdown of academic impact, for papers by Katrien Fransen
Rankless by CCL
2026